CBLL (CeriBell) Total Equity: $140.81 Mil (As of Mar. 2026)


CBLL CeriBell Inc CBLL
12 GF Score
Price $18.93
! 3 Warning Signs
View Full Analysis

What is CeriBell Total Equity?

CeriBell CBLL +1.69% 12 Total Equity is $140.81 Mil as of Mar. 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

CeriBell's total equity for the quarter that ended in Mar. 2026 was $140.81 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

CeriBell Total Equity Historical Data

* Premium members only.

The historical data trend for CeriBell's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Total Equity Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
-86.40 -112.25 191.17 155.34

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.88 172.16 164.08 155.34 140.81
CBLL
12GF Score
CeriBell Inc CBLL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

CeriBell's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=195.803-40.467
=155.34

CeriBell's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=178.078-37.265
=140.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $140.81 Mil mean?
CeriBell (CBLL) has a Total Equity of $140.81 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for CeriBell and its competitors.
Is CeriBell's Total Equity too high?
CeriBell's current Total Equity is $140.81 Mil. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Total Equity compare to LMRI and SIBN?
CeriBell's Total Equity of $140.81 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for CeriBell and its competitors. CeriBell's current Total Equity is $140.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Total Equity of $140.81 Mil. The current Total Equity is $140.81 Mil. CeriBell's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For CeriBell (CBLL), the current Total Equity is $140.81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.93
Price